Thymoglobulin Injection, Powder, Lyophilized, For Solution
Product Images NDC 58468-0080

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Thymoglobulin (NDC 58468-0080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genzyme Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chart (Thymoglobulin 01)

A line graph depicting mean T-cell counts over seven days following initiation of Thymoglobulin therapy. The y-axis shows mean T-cell counts with standard error of the mean (SEM), ranging from 0 to 500. The x-axis shows time in days from 1 to 7. Two lines represent CD2 and CD3 counts, both sharply declining from around 400 to near zero by day 2, remaining low through day 7.*

FDA Label Image

Principal Display Panel (25 mg Vial Carton)

Packaging label for Thymoglobulin 25 mg per vial, an Anti-thymocyte Globulin (Rabbit) injection powder for solution. The label states intravenous infusion use, single-dose vial, no preservative, and storage instructions including refrigeration and protection from light. Manufactured by Genzyme Corporation, Cambridge, MA, with origin in France by Genzyme Polyclonals S.A.S.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.